Echo Therapeutics announced positive results from its clinical trial of the Symphony tCGM System, a non-invasive, wireless, transdermal continuous glucose monitoring system, in major general surgery and cardiothoracic surgery patients. This study is the second of two studies in critically ill patients.
Data from this study demonstrate that Symphony successfully and continuously monitored glucose levels in the intensive care unit at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania.